Literature DB >> 3614216

Immunogenicity of a free synthetic peptide: carrier-conjugation enhances antibody affinity for the native protein.

M Mariani, L Bracci, R Presentini, D Nucci, P Neri, G Antoni.   

Abstract

The synthetic peptide 166-174 of hCS sequence, corresponding to an antigenic determinant of the protein, was used to elicit MAbs to the native hCS molecule. The synthetic peptide was administered according to different immunization protocols to BALB/c mice, both in the free form or conjugated to carrier proteins. Spleens and popliteal lymph nodes from primed mice were fused with a myeloma cell line to produce MAbs, and selected clones were characterized for isotype and affinity. Spleen fusions gave rise to IgM MAbs, whereas lymph node fusions gave preferentially IgG MAbs. No correlation was found between antibody class and affinity since affinity is highly increased by carrier-conjugation, while it did not enhance IgG production. The free synthetic peptide showed a low immunogenicity: affinities of MAbs produced ranged from 10(5) to 10(7) l/mole, an average 1000-fold lower than the values obtained with carrier-conjugated peptide. In one case, however, carrier conjugation did not give rise to anti-hCS MAbs. Overall, these studies provide a rational approach to the production of anti-protein MAbs by synthetic peptide immunization and offer the opportunity to obtain MAbs of the desired isotype and affinity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3614216     DOI: 10.1016/0161-5890(87)90148-9

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

Review 1.  Protein antigenicity.

Authors:  M H Van Regenmortel
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

2.  Generation of human monoclonal antibodies that confer protection against pertussis toxin.

Authors:  M Zaccolo; S Roggero; D Armellini; L Pegoraro; R Rappuoli; F Malavasi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 3.  Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.

Authors:  Elisabeth I Minder; Jasmin Barman-Aksoezen; Xiaoye Schneider-Yin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

4.  Amino acid substitutions outside a preselected antigenic region in hemoglobin affect the binding to monoclonal antibodies obtained by immunization with the synthetic region.

Authors:  M Oshima; S Nakamura; M Z Atassi
Journal:  J Protein Chem       Date:  1993-08

5.  Recognition of liposome-bound antigens by antipeptide antibody.

Authors:  Y Sohma; R Fujita; S Katoh; E Sada
Journal:  Appl Biochem Biotechnol       Date:  1993-03       Impact factor: 2.926

6.  Cloning, characterization, and modeling of a monoclonal anti-human transferrin antibody that competes with the transferrin receptor.

Authors:  M Orlandini; A Santucci; A Tramontano; P Neri; S Oliviero
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

7.  Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptides.

Authors:  C Joisson; F Kuster; S Plaué; M H Van Regenmortel
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  A universal antibody-derived targeting agent.

Authors:  R A Spooner; M P Deonarain; P Savage; A A Epenetos
Journal:  Cell Biophys       Date:  1993 Jan-Jun

9.  CD38 binding to human myeloid cells is mediated by mouse and human CD31.

Authors:  A L Horenstein; H Stockinger; B A Imhof; F Malavasi
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

10.  Dodecin as carrier protein for immunizations and bioengineering applications.

Authors:  Florian Bourdeaux; Yannick Kopp; Julia Lautenschläger; Ines Gößner; Hüseyin Besir; R Martin Vabulas; Martin Grininger
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.